Whole genome (60x) and transcriptome (30 M reads) sequencing of tumor and normal samples from 1.000+ patients with colorectal cancer included in U-CAN. Whole genome (15-20X) and transcriptome (500 M reads) for a subset of ~100 samples from the cohort above.